T he U.S. Food and Drug Administration's (FDA) Office of Minority Health and Health Equity (OMHHE) is committed to protecting and promoting the health of diverse populations through outreach, communication, and research. One of our key goals is supporting efforts that reduce health disparities. To further this effort, we have partnered with FDA's Center for Tobacco Products (CTP) and the Society for Public Health Education to produce this Health Promotion Practice (HPP) journal supplement. The supplement is just one of many strategies FDA is using to raise awareness around important topics that disproportionally affect minority communities. Our hope is that the articles included here will inspire stakeholders and provide the evidence and information needed to contribute to sustainable programs that will make our communities healthier now and in the future.
Health equity is the "attainment of the highest level of health for all people" (Office of Disease Prevention and Health Promotion, 2019) . Making health equity a reality in the United States will require multidisciplinary stakeholders to work toward removing systemic barriers that can hinder positive health outcomes. Lack of access to health care; safe housing; available, low-cost transportation; and educational options and, in some cases, language issues are common barriers experienced by many racial and ethnic minorities and underserved and underrepresented groups (Adler, Glymour, & Fielding, 2016) . These barriers can be critical to a person's ability to make good decisions about their health and the health of their family. The efforts described in the HPP journal supplement illustrate how specific efforts can break through some of these barriers. The focus of the supplement, the widespread use of tobacco products among minority communities, is a health area of concern to many stakeholders.
> > THe Problem
The federal government first recognized smoking as a major public health issue in 1964, with the release of the U.S. Surgeon General Report on Smoking. Despite federal warnings about the dangers of smoking, cigarette smoking is still the leading cause of preventable death in the United States, accounting for about 480,000 deaths annually (Abram & Zeller, 2019; Centers for Disease Control and Prevention, 2018b) . Data show overall tobacco use has declined since 1964, but disparities still exist for tobacco prevalence, premature death, and secondhand smoke exposure. Tobacco use is more common among people in lowsocioeconomic (Adler et al., 2016) , racial minority, and ethnic minority groups. For example, in 2017, American Indians/Alaska Natives had the highest percentage of tobacco use among adults (29.8%), followed by Whites (21.4%), African Americans (20.1%), Hispanics (12.7%), and Asians (8.9%; Centers for Disease Control and Prevention, 2018a). Cigarette smoking is higher among lesbian, gay, and bisexual (LGB) persons than heterosexual individuals at 20.5% and 15.3%, respectively (Centers for Disease Control and Prevention, 2018d). The transgender population is also vulnerable to smoking because of high rates of substance abuse, depression, HIV, and social and employment discrimination (Centers for Disease Control and Prevention, 2018d). Another population of concern is youth because tobacco use almost always begins during adolescence, making youth increasingly vulnerable to tobacco use. Each day over 2,000 young people smoke their first cigarette or cigar (Centers for Disease Control and Prevention, 2019a), and 1,300 use smokeless tobacco (U.S. FDA, 2019d). About 27.1% of high school students and 7.2% of middle school students report using tobacco products (Centers for Disease Control and Prevention, 2019b). FDA believes that it is critically important to implement strategies to prevent initial tobacco exposure.
Tobacco products have historically been marketed, and continue to be marketed, to certain communities, enticing youth with flavored tobacco products, visually appealing packaging, and new types of tobacco and nicotine products, such as vaping, hookah, and e-cigarettes. Some sources estimate that as much as $8.7 billion is spent on advertising and promoting cigarettes, with $759.3 million spent on smokeless tobacco (Centers for Disease Control and Prevention, 2018c). Product marketing strategies often focus on each target audience's desires and views.
> > FDA'S CommITmeNT To TACklINg THe

TobACCo Problem
FDA's CTP works to protect Americans from tobaccorelated death and disease by regulating the manufacture, distribution, and marketing of tobacco products and by educating the public, especially young people, about tobacco products and the dangers their use poses to themselves and others. FDA's OMHHE supports CTP's efforts by working with internal and external stakeholders to reduce tobacco use among minorities and underserved and underrepresented groups. FDA's OMHHE work focuses on two broad areas: (1) research/ collaboration and (2) outreach/communication. Our Research and Collaboration Program aims to advance minority health-focused research and appropriate inclusion of racial/ethnic minority populations in clinical trials. Our Outreach and Communication Program works to improve FDA's communication with racial and ethnic minority populations (U.S. FDA, 2019c). We do this in part by supporting promotion of CTP's communication campaigns, many of which are geared toward diverse communities. Another example includes this HPP journal supplement, which is intended to raise awareness among stakeholders who are addressing tobacco prevention and cessation within their communities about tobacco and health equity issues plaguing our most vulnerable and underserved communities.
> > FDA'S CTP AUTHorITy AND ACTIoNS
The CTP has regulated cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco products since June 2009, after Congress passed and the President signed the Family Smoking Prevention and Tobacco Control Act (Abram & Zeller, 2019; U.S. FDA, 2018a) . This Act gave FDA the authority to regulate the manufacture, distribution, and marketing of tobacco products. In 2016, this authority was extended to all tobacco products, including e-cigarettes, cigars, hookah, and pipe tobacco (U.S. FDA, 2018a). The Tobacco Control Act specifically restricts tobacco marketing and sales to youth; requires warning labels on smokeless tobacco products; requires the ingredients in tobacco products be disclosed; preserves state, local, and tribal authorities in specific respects; and ensures that "modified risk" 1 claims are supported by scientific evidence (U.S. FDA, 2018a).
To implement the Act, CTP released a multiyear road map called the Comprehensive Plan for Tobacco and Nicotine Regulation with the goal of reducing tobaccorelated disease and death in the United States. Key features of this plan include (1) regulatory policies on addiction, appeal, and cessation; (2) science-based review of tobacco products; and (3) a youth tobacco prevention plan. Resulting actions have included educational campaigns, warning letters to companies about illegal advertising, and research to understand the associated risk of tobacco use.
Health Education Campaigns
Using equity-focused strategies, like school-based interventions or media-based activities, can postpone or prevent smoking onset in 20% to 40% of U.S. adolescents (National Center for Chronic Disease Prevention and Health Promotion [U.S.] Office on Smoking and Health, 2012) . Therefore, each program is tailored to a specific group, is culturally relevant, and uses cultural influencers likes parents, media figures, and community members to raise awareness around the importance to either quit smoking or to never start. Two examples of groundbreaking FDA prevention campaigns include Fresh Empire and This Free Life.
FDA's Fresh Empire campaign is designed to prevent and reduce tobacco use among multicultural teens between the ages of 12 and 17 years who identify with the hip-hop peer crowd. Launched in 2015, it is a traditional, paid media campaign with engagement through multiple digital platforms (social media, interactive website), print, out of home (e.g., billboards), and radio advertisements, plus local-level outreach. Advertisements feature African American, Hispanic, and Asian American/ Pacific Islander youth delivering aspirational messaging to counter protobacco imagery and convey to youth that tobacco is not a necessary part of the hip-hop lifestyle. Keep It Fresh is the tagline used to emphasize to youth that living tobacco free will help them achieve their goals and ensure a positive self-image (U.S. FDA, 2019b).
Members of the lesbian, gay, bisexual, transgender, queer (LGBTQ) community are especially susceptible to initiating smoking and are two times more likely to smoke than their peers (Agaku et al., 2014) . Often, coming out is a period of increased vulnerability due to perceived and actual stigma, and tobacco use can suggest a misplaced sense of community due to the feeling that they are not desired within their communities. FDA's This Free Life campaign was tailored toward the 2 million persons who self-identify as LGBTQ, who are between the ages of 18 and 24 years, and who smoke occasionally. Like Fresh Empire, This Free Life uses digital outreach, select traditional paid media placements, and local-level outreach. Grounded in science, authentic and credible messages to engage LGBTQ young adults were developed to appeal to their core ideals, similar life experiences, and common interests, enabling the campaign to reach diverse subpopulations of the LGBTQ community. Acknowledging that coming out is hard, the campaign reflects the audience's desire to be free as it relates to their lives and experiences as LGBTQ young adults. The tagline is Freedom to Be, Tobacco-Free.
Research Underway
In addition to health education campaigns, FDA funds research to better understand tobacco use and associated risks so that we can better address and reduce the public health burden of tobacco in the United States (U.S. FDA, 2019e). Research currently underway targets core areas-toxicity, addiction, health effects, behavior, communication, marketing influences, and impact analysis (U.S. FDA, 2018d). One study of interest is the Population Assessment of Tobacco and Health, which is a collaboration between FDA and the National Institutes of Health. This longitudinal study follows participants over time to understand the underlying reasons why people start using tobacco, quit tobacco, and restart if they have previously quit, and how different tobacco products affect health over the life span. The findings will help inform FDA's actions related to tobacco products and support the goals of the Family Smoking Prevention and Tobacco Control Act (U.S. FDA, 2018a, 2019a).
Approved Medical Products to Help People Quit
Lastly, FDA has approved several medical products to help people quit tobacco use. Undoubtedly, smoking cessation is difficult because it is an addiction that is hard to break, especially as a person ages. Cessation products include over-the-counter nicotine replacement therapies, like skin patches, chewing gum, lozenges, nicotine inhalers, and nicotine nasal sprays as well as prescription products to aid smoking cessation.
> > CoNClUSIoN
Achieving health equity remains a national public health goal. At FDA, we strive to advance health equity by implementing programs and developing resources that are culturally tailored, linguistically appropriate, and clinically relevant so our diverse consumers can make informed decisions about their health. Our hope is that the articles you read here will inspire you to do what you can to help build sustainable programs that will make our communities healthier and tobacco free.
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